PharMerica Corp. Company Profile (NYSE:PMC)

Analyst Ratings

Consensus Ratings for PharMerica Corp. (NYSE:PMC) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $31.83 (19.81% upside)

Analysts' Ratings History for PharMerica Corp. (NYSE:PMC)
Show:
DateFirmActionRatingPrice TargetActions
6/7/2016Bank of America Corp.Initiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Barrington ResearchReiterated RatingOutperform$30.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Credit Suisse Group AGInitiated CoverageOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016KeyCorpLower Price TargetOverweight$39.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2014Goldman Sachs Group Inc.Initiated CoverageNeutral$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for PharMerica Corp. (NYSE:PMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/9/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2016Q116$0.43$0.45$509.45 million$524.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2016Q415$0.41$0.45$506.40 million$520.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015Q315$0.36$0.39$480.35 million$498.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q215$0.33$0.37$491.66 million$497.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.43$0.48$500.95 million$511.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414$0.43$0.45$491.99 million$523.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314$0.40$0.45$439.63 million$470.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.36$0.40$432.70 million$448.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.33$0.37$417.76 million$452.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2014Q413$0.38$0.44$421.16 million$433.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.32$0.49$398.02 million$442.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013Q2 2013$0.34$0.44$414.15 million$458.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013$0.34$0.46$435.10 million$439.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2013Q4 2012$0.29$0.12$432.43 million$433.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.30$0.33$446.36 million$442.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.30$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.27$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012$0.21$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011$0.20$0.31ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$0.20$0.32ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011$0.20$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$0.17$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PharMerica Corp. (NYSE:PMC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.36$0.48$0.41
Q2 20162$0.37$0.46$0.42
Q3 20162$0.38$0.51$0.45
Q4 20162$0.41$0.53$0.47
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PharMerica Corp. (NYSE:PMC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for PharMerica Corp. (NYSE:PMC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/2/2015Robert A MckaySVPSell2,993$34.42$103,019.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Mark LindemoenSVPSell3,790$34.71$131,550.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Robert A MckaySVPSell7,000$32.75$229,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Gregory S WeisharCEOSell104,150$32.63$3,398,414.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Mark LindemoenSVPSell4,500$33.27$149,715.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Berard TomassettiCAOSell3,344$26.44$88,415.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Thomas A CanerisSVPSell7,495$26.52$198,767.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Robert A MckaySVPSell20,000$26.74$534,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Robert A OakleyDirectorSell8,399$26.55$222,993.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Thomas CanerisSVPSell12,192$28.60$348,691.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Gregory WeisharCEOSell60,000$26.27$1,576,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Robert MckaySVPSell18,646$26.08$486,287.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Berard TomassettiCAOSell3,812$25.22$96,138.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Thomas CanerisSVPSell14,357$25.60$367,539.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/22/2013Thomas GerrityDirectorSell3,271$20.56$67,251.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Berard TomassettiCAOSell4,097$20.55$84,193.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013Berard TomassettiCAOSell9,724$15.68$152,472.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PharMerica Corp. (NYSE:PMC)
DateHeadline
07/18/16 03:10 PMPharMerica Corp. – Value Analysis (NYSE:PMC) : July 18, 2016 -
07/16/16 09:08 AMPharMerica Corporation : Announces Second Quarter 2016 Earnings Call and Webcast
07/14/16 03:48 PMPharMerica Corporation Announces Second Quarter 2016 Earnings Call and Webcast - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--Jul. 14, 2016-- PharMerica Corporation (NYSE: PMC) announced today that it will provide an online webcast of its second quarter 2016 earnings conference call on Tuesday, ...
07/11/16 05:51 PMShare Valuation Recap for: PharMerica Corporation (NYSE:PMC) - Telanagana Press
07/11/16 10:31 AMStock on the Rise for the Quarter: PharMerica Corporation (NYSE:PMC) - Engelwood Daily
07/11/16 10:31 AMStock Rating Watch and Earnings Insight for Pharmerica Corporation (NYSE:PMC) - Press Telegraph
07/11/16 10:31 AMStock Performance Rundown on: PharMerica Corporation (NYSE:PMC) - Press Telegraph
07/11/16 10:31 AMNext Weeks Broker Price Targets For Pharmerica Corporation (NYSE:PMC) - Fiscal Standard
07/11/16 08:29 AMPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : July 11, 2016 -
07/07/16 05:54 PMPharmerica Corporation (NYSE:PMC) Shorted Shares Decreased By 6.21% - Engelwood Daily
07/06/16 10:31 AMStock Tracking Down This Month; Investor Alert on PharMerica Corporation (NYSE:PMC) - Engelwood Daily
07/05/16 05:36 PMCan Pharmerica Corporation (NYSE:PMC) Improve on the Earnings Front? - Engelwood Daily
07/05/16 05:36 PMPharmerica Corp Stock Decreased as Institutional Investors Enter - Engelwood Daily
07/05/16 05:36 PMShare Performance Recap for: PharMerica Corporation (NYSE:PMC) - Press Telegraph
07/05/16 05:36 PMPharmerica Corporation (NYSE:PMC) Broker Price Targets For The Coming Week - Fiscal Standard
07/05/16 05:36 PMCompany Stock Focus for Pharmerica Corporation (NYSE:PMC): Which Way Will Shares Head? - Press Telegraph
07/02/16 05:30 PMHow Many PharMerica Corporation (NYSE:PMC)'s Analysts Are Bearish? - Press Telegraph
07/01/16 08:37 AMCovering the Bases on Pharmerica Corporation (NYSE:PMC): Where is the Stock Going? - Press Telegraph
07/01/16 08:37 AMNew Broker Ratings For Pharmerica Corporation (NYSE:PMC) - FTSE News
07/01/16 08:37 AMPharmerica Corporation (NYSE:PMC) Company Rating and Target Watch - Telanagana Press
06/29/16 07:17 AM5 Stocks with Earnings Beat Potential to Buy Now -
06/28/16 11:09 PMTwo Small-Cap Healthcare Stocks That are Cheap Buys Right Now -
06/22/16 08:30 AMZacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival -
06/21/16 03:08 PMPHARMERICA CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/15/16 07:40 AMWhy the Earnings Streak Will Continue for PharMerica (PMC) -
06/14/16 10:40 AMPharmerica Corporation (PMC) - Financial and Strategic SWOT Analysis Review - New Market Research Report
06/13/16 07:22 AMHedge Funds’ Favorite Stocks With Low Price-to-Cash-Flow Ratios -
06/07/16 07:42 AMSurging Earnings Estimates Signal Good News for PharMerica (PMC) -
06/03/16 06:24 PMPharmerica Corporation (NYSE:PMC) Price Target and Stock Rating Synopsis
05/23/16 11:46 AMIs PharMerica Corporation (PMC) a Good Stock to Buy? -
05/17/16 10:50 AMPharMerica wants the Supreme Court to rethink this decision -
05/17/16 07:42 AMPharMerica to Present at the UBS Global HealthCare Conference - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--May 17, 2016-- PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, and oncology pharmacy services, today announced that Gregory ...
05/13/16 08:05 AMPharmerica's growth strategy is really generic -
05/12/16 10:26 AMPharMerica Corp. :PMC-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/06/16 01:20 PMPharMerica's 1Q earnings fell sharply but beat expectations -
05/06/16 10:07 AMEdited Transcript of PMC earnings conference call or presentation 6-May-16 2:00pm GMT -
05/06/16 07:24 AMPharMerica Reports First Quarter 2016 Results - [at noodls] - Financial Results Exceed Expectations Strong Cash Flow From Operating Activities Industry Leading Generic Dispensing Rate Increases to Record 86.6% Reaffirms Annual 2016 Guidance LOUISVILLE, Ky.--(BUSINESS ...
05/06/16 07:08 AMPharMerica beats 1Q profit forecasts -
04/20/16 10:39 AMPharMerica Corp. – Value Analysis (NYSE:PMC) : April 20, 2016 -
04/19/16 07:07 AMPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : April 19, 2016 -
04/12/16 03:26 PMPharMerica Corporation Announces First Quarter 2016 Earnings Call and Webcast - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--Apr. 12, 2016-- PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its first quarter 2016 earnings conference call on Friday, ...
04/04/16 03:51 PMPHARMERICA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
04/02/16 01:42 PMPharmerica Corp (NYSE:PMC) Sentiment Improved, Despite Downtrend - RiversideGazette.com - Pharmerica Corp (NYSE:PMC) Sentiment Improved, Despite DowntrendRiversideGazette.comAlso, the number of active investment managers holding Pharmerica Corp in their top 10 equity positions decreased from 3 to 2 for a decrease of 1. Sold All: 16 Reduced: 61 Increased: 60 New Position: 27. PharMerica Corporation is an institutional ...Stock Earnings in Review: PharMerica Corporation (NYSE:PMC)CWRU ObserverFresh: How did Barclays Capital rate Pharmerica Corp.?The Duncan Independent (press release) (blog)all 3 news articles »
03/29/16 03:36 PMPharMerica Announces Date of 2016 Annual Meeting of Shareholders - [at noodls] - LOUISVILLE, Ky.--(BUSINESS WIRE)--Mar. 29, 2016-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced ...
03/29/16 10:04 AMETF’s with exposure to PharMerica Corp. : March 29, 2016 -
03/24/16 12:40 PMPharMerica execs could get big bonus checks -
03/23/16 04:03 PMPHARMERICA CORP Files SEC form 8-K, Change in Directors or Principal Officers -
03/14/16 08:29 AMPharMerica downgraded by UBS -
03/12/16 02:01 PMPharmerica Corporation Common S (PMC) Hits a New 52-Week Low - Stock prices of Pharmerica Corporation Common S (NYSE:PMC) exerienced a new one year low price reaching $20.21 on Thursday. The company traded down with a change of $0.67 ending the day at $20.74. Volume was 508,860 shares and the stock hit a high of $21.64.
03/07/16 11:53 AMPharMerica Corp. :PMC-US: Earnings Analysis: Q4, 2015 By the Numbers -

Social

About PharMerica Corp.

PharMerica Corp. logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Stores
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: PMC
  • CUSIP: 71714F10
Key Metrics:
  • Previous Close: $26.57
  • 50 Day Moving Average: $25.42
  • 200 Day Moving Average: $25.43
  • P/E Ratio: 27.68
  • P/E Growth: 1.40
  • Market Cap: $816.60M
  • Beta: 0.67
  • Current Year EPS Consensus Estimate: $2.02 EPS
  • Next Year EPS Consensus Estimate: $2.28 EPS
Additional Links:
PharMerica Corp. (NYSE:PMC) Chart for Wednesday, July, 27, 2016